InsidersTradesSigma
Follow the 제이브이엠 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 제이브이엠 has logged 12 public disclosures. The latest transaction was filed on 6 October 2022 (Purchase). Among the most active insiders: 김상욱. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
12 of 12 declarations
제이브이엠 is a healthcare and pharmaceutical company listed on the XKRX. It specializes in the development and marketing of pharmaceutical products.